Literature DB >> 29099931

Clinical Fractures Among Older Men With Diabetes Are Mediated by Diabetic Complications.

Richard H Lee1,2, Richard Sloane1,2, Carl Pieper1, Kenneth W Lyles1,2, Robert A Adler3,4, Courtney Van Houtven1,2, Joanne LaFleur5,6, Cathleen Colón-Emeric1,2.   

Abstract

Introduction: Type 2 diabetes mellitus among older women has been associated with increased bone mineral density, but paradoxically with increased fracture risk. Findings among older men have varied, and potential mechanisms have not been fully elucidated.
Methods: A retrospective study of male veterans 65 to 99 years of age who received primary care in the Veterans Health Administration from 2000 to 2010, using administrative data from all 146 Veterans Health Administration medical centers linked to Centers for Medicare and Medicaid Services Medicare fee-for-service data. Potential mediating factors of the diabetes-associated risk were evaluated using negative binomial regression models with the outcomes of any clinical fracture and hip fracture.
Results: Of 2,798,309 Veterans included in the cohort, 900,402 (32.3%) had a diagnosis of diabetes. After adjusting for age, race, ethnicity, body mass index, alcohol and tobacco use, rheumatoid arthritis, and corticosteroid use, the risk of any clinical fracture associated with diabetes was 1.22 (95% confidence interval, 1.21 to 1.23) and that of hip fracture was 1.21 (95% confidence interval, 1.19 to 1.23). Significant mediating factors included peripheral neuropathy, cardiovascular disease, and congestive heart failure, with 45.5% of the diabetes-associated fracture risk explained by these diagnoses. Conclusions: Older male Veterans with diabetes have a 22% increased risk of incident clinical fracture compared with those without. A significant portion of this risk is explained by diabetes-related comorbidities, specifically peripheral neuropathy and congestive heart failure. Identification of these mediating factors suggests possible mechanisms, as well as potential interventions.
Copyright © 2017 Endocrine Society

Entities:  

Mesh:

Year:  2018        PMID: 29099931      PMCID: PMC5761492          DOI: 10.1210/jc.2017-01593

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  46 in total

1.  Bone loss in rats with aldosteronism.

Authors:  Aliye L Runyan; Vikram S Chhokar; Yao Sun; Syamal K Bhattacharya; John W Runyan; Karl T Weber
Journal:  Am J Med Sci       Date:  2005-07       Impact factor: 2.378

2.  Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure.

Authors:  Rami N Khouzam; Dwight A Dishmon; Victor Farah; Sherri D Flax; Laura D Carbone; Karl T Weber
Journal:  Am J Med Sci       Date:  2006-01       Impact factor: 2.378

3.  A Novel Analytic Technique to Measure Associations Between Circulating Biomarkers and Physical Performance Across the Adult Life Span.

Authors:  Matthew J Peterson; Dana K Thompson; Carl F Pieper; Miriam C Morey; Virginia B Kraus; William E Kraus; Patrick Sullivan; Gerda Fillenbaum; Harvey J Cohen
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-03-05       Impact factor: 6.053

4.  Factors associated with screening or treatment initiation among male United States veterans at risk for osteoporosis fracture.

Authors:  Richard E Nelson; Jonathan R Nebeker; Brian C Sauer; Joanne LaFleur
Journal:  Bone       Date:  2012-01-18       Impact factor: 4.398

5.  FRAX underestimates fracture risk in patients with diabetes.

Authors:  Lora M Giangregorio; William D Leslie; Lisa M Lix; Helena Johansson; Anders Oden; Eugene McCloskey; John A Kanis
Journal:  J Bone Miner Res       Date:  2012-02       Impact factor: 6.741

6.  Fracture risk in diabetic elderly men: the MrOS study.

Authors:  Nicola Napoli; Elsa S Strotmeyer; Kristine E Ensrud; Deborah E Sellmeyer; Douglas C Bauer; Andrew R Hoffman; Thuy-Tien L Dam; Elizabeth Barrett-Connor; Lisa Palermo; Eric S Orwoll; Steven R Cummings; Dennis M Black; Ann V Schwartz
Journal:  Diabetologia       Date:  2014-06-09       Impact factor: 10.122

7.  Identification of fractures from computerized Medicare files.

Authors:  W A Ray; M R Griffin; R L Fought; M L Adams
Journal:  J Clin Epidemiol       Date:  1992-07       Impact factor: 6.437

8.  Older women with diabetes have a higher risk of falls: a prospective study.

Authors:  Ann V Schwartz; Teresa A Hillier; Deborah E Sellmeyer; Helaine E Resnick; Edward Gregg; Kristine E Ensrud; Pamela J Schreiner; Karen L Margolis; Jane A Cauley; Michael C Nevitt; Dennis M Black; Steven R Cummings
Journal:  Diabetes Care       Date:  2002-10       Impact factor: 19.112

9.  TNF-α is upregulated in T2DM patients with fracture and promotes the apoptosis of osteoblast cells in vitro in the presence of high glucose.

Authors:  Mingqi Sun; Junli Yang; Jianzhong Wang; Ting Hao; Dianming Jiang; Guoyu Bao; Guanghui Liu
Journal:  Cytokine       Date:  2016-03-03       Impact factor: 3.861

10.  Bone mineral density scans in veterans.

Authors:  Elizabeth Bass; Etienne Pracht; Philip Foulis
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more
  16 in total

1.  Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.

Authors:  Derek LeRoith; Geert Jan Biessels; Susan S Braithwaite; Felipe F Casanueva; Boris Draznin; Jeffrey B Halter; Irl B Hirsch; Marie E McDonnell; Mark E Molitch; M Hassan Murad; Alan J Sinclair
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

2.  Glycemic Control and Insulin Treatment Alter Fracture Risk in Older Men With Type 2 Diabetes Mellitus.

Authors:  Richard H Lee; Richard Sloane; Carl Pieper; Kenneth W Lyles; Robert A Adler; Courtney Van Houtven; Joanne LaFleur; Cathleen Colón-Emeric
Journal:  J Bone Miner Res       Date:  2019-10-09       Impact factor: 6.741

3.  Major osteoporosis fracture prediction in type 2 diabetes: a derivation and comparison study.

Authors:  Xiao-Ke Kong; Zhi-Yun Zhao; Deng Zhang; Rui Xie; Li-Hao Sun; Hong-Yan Zhao; Guang Ning; Wei-Qing Wang; Jian-Min Liu; Bei Tao
Journal:  Osteoporos Int       Date:  2022-05-18       Impact factor: 5.071

4.  Acetylcholinesterase Inhibitors Are Associated with Reduced Fracture Risk among Older Veterans with Dementia.

Authors:  Abayomi N Ogunwale; Cathleen S Colon-Emeric; Richard Sloane; Robert A Adler; Kenneth W Lyles; Richard H Lee
Journal:  J Bone Miner Res       Date:  2019-12-12       Impact factor: 6.741

5.  1,25-Dihydroxyvitamin D suppresses M1 macrophages and promotes M2 differentiation at bone injury sites.

Authors:  Samiksha Wasnik; Charles H Rundle; David J Baylink; Mohammad Safaie Yazdi; Edmundo E Carreon; Yi Xu; Xuezhong Qin; Kin-Hing William Lau; Xiaolei Tang
Journal:  JCI Insight       Date:  2018-09-06

Review 6.  Influence of glycemic control and hypoglycemia on the risk of fracture in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies.

Authors:  K Hidayat; Q-L Fang; B-M Shi; L-Q Qin
Journal:  Osteoporos Int       Date:  2021-04-16       Impact factor: 4.507

7.  Effect of peripheral neuropathy on bone mineral density in adults with diabetes: A systematic review of the literature and meta-analysis.

Authors:  Mahshid Mohseni; Pooya Hosseinzadeh; Roberto Civitelli; Seth Eisen
Journal:  Bone       Date:  2021-03-20       Impact factor: 4.626

8.  Correlation Between Serum miR-154-5p and Osteocalcin in Males and Postmenopausal Females of Type 2 Diabetes With Different Urinary Albumin Creatinine Ratios.

Authors:  Huiwen Ren; Xiaoyu Ma; Ying Shao; Jinyu Han; Min Yang; Qiuyue Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-06       Impact factor: 5.555

9.  Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data.

Authors:  J Ha; C Jeong; K-D Han; Y Lim; M K Kim; H-S Kwon; K-H Song; M I Kang; K-H Baek
Journal:  Osteoporos Int       Date:  2021-07-31       Impact factor: 4.507

Review 10.  Skeletal Fragility in Type 2 Diabetes Mellitus.

Authors:  Jakob Starup-Linde; Katrine Hygum; Bente Lomholt Langdahl
Journal:  Endocrinol Metab (Seoul)       Date:  2018-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.